Notably, prostate cancer-associated SPOP mutants are deficient in binding and promoting the degradation of substrates, leading to increased prostate cancer cell proliferation and invasion [3, 14], indicating the loss of function of SPOP mutations and the tumor-suppressive role of SPOP in prostate cancer. Here, SPOP is linked to prostate carcinoma.